Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe
11/05/2026 14:08
May 11 (Reuters) - Evolus Inc EOLS.O: EVOLUS ANNOUNCES COMMERCIAL LAUNCH OF ESTYME® INJECTABLE HYALURONIC ACID GELS IN EUROPE Source text: ID:nBw75w1Bpa Further company coverage: EOLS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe